Milltrust International's Agbio Genesis is a purpose-built investment vehicle investing in high-potential companies focusing on innovative science that will become seminal to the green revolution heralding the new agricultural age. Agriculture is at heart and centre of our relationship with the environment and humanity’s endeavour to continue. With the global population increasing each day and environmental destruction proliferating, a reinvigoration of our food system is essential and will be driven by technological and scientific advances such as IPSC stem cell technology, genetics and breeding innovations.
BugEra improve the natural traits of the Black Soldier Fly (BSF) through genetic engineering – creating a Modified Black Soldier Fly (M-BSF). This allows BugEra to rapidly develop novel strains to deliver an array of safe and sustainable bi-products. Backed by global leader in the production of biofuel, BugEra's first strain is already delivering for the rapidly expanding biofuel industry, decarbonising transport sectors such as aviation and shipping.
Founded in 2021, Cody Genetics is an animal biotechnology company that applies gene-editing technology to benefit livestock farming. The company enables breeders to receive sperm/oocytes that not only will have a pre-determined sex, but that in turn will only produce gender-biased offspring through unassisted reproduction. The gene-editing technology offered by Cody technology dramatically improve animal welfare by preventing the culling of billions of animals and immensely reduces resource-use.
Roslin Technologies is a biotech company pioneering sustainable solutions to support the food and agriculture sectors. Its mission is to advance disruptive innovations to improve how we produce proteins to feed the world’s increasing population. Its primary focus is on animal stem cells – and their huge potential as ingredients for supporting the global cultivated meat market.
AgShift is an AI based food technology start-up working on designing world's most advanced autonomous food inspection system. AgShift's software blends patented Deep Learning models with Computer vision to make food inspections autonomous, consistent and standardized at scale. AgShift is empowering the world's largest food organizations to reduce global food loss and waste.EXIT
Backed by our investee company Roslin Technologies which we seeded in 2016, Protenga develops insect technology to foster a sustainable, circular, and regenerative food system. Protenga aims to produce the world’s most sustainable pet food from farm to fork through a vertically integrated supply chain.EXIT
Cambridge-based PragmatIC is a world leader in ultra-low-cost flexible electronics. Their flexible integrated circuits (FlexICs) are thinner than a human hair and can be invisibly embedded in objects, enabling innovators to create novel solutions to everyday problems that are not practical with conventional electronics.
CorePower is a UK-based development company, specializing in scalable atomic power technology for ocean transport and heavy industry. In partnership with leading international corporations, CorePower aims to deliver durable zero-emission energy for floating industrial production and deep-sea shipping.
MyDoc is Asia’s leading telemedicine service company. MyDoc’s fully integrated online-to-offline platform streamlines all aspects of primary healthcare into one easy-to-use solution connecting patients to doctors, pharmacies, diagnostic laboratories, clinical-grade health trackers, Fortune 500 and SME employers, and insurers.
Roslin Technologies is a biotech company pioneering sustainable solutions to support the food and agriculture sectors. Its mission is to advance disruptive innovations to improve how we produce proteins to feed the world’s increasing population. Its primary focus is on animal stem cells – and their huge potential as ingredients for supporting the global cultivated meat market..
Cambridge medtech start-up 52 North Health has developed an innovative device, Neutrocheck, that rapidly identifies chemotherapy patients at risk of a life-threatening complication called neutropenic sepsis. Through improving triaging, Neutrocheck has the potential to save thousands of lives, free up valuable healthcare resources, and make patients' lives easier, simpler, and better.
GlycoScoreDx, a UK-based diagnostics company, has designed a novel blood test revolutionising how prostate cancer is developed. Using a unique combination of biomarkers, the test provides a clear picture of clinically relevant prostate cancer, ensuring that only patients at risk need to undergo the invasive procedure of prostate-tissue biopsy.
Attomarker, a spin-out company from the University of Exeter, has produced a unique COVID-19 triple antibody testing device, giving a real-time analysis of immunity levels. The blood sample analysis tracks both the waning immunity from vaccines and ‘natural immunity’ boosts from COVID infections. The data it generates amounts to a personal COVID-risk profile for each individual.
Singapore-based Safe Space offers a comprehensive online and offline mental health solution using therapy sessions and other resources. Using this system, patients and therapists can connect quickly, and patients can access therapy from anywhere in the world. The Safe Space platform strengthens mental resilience by providing quality, affordable tele-therapy care and prevention education.
Oncoshot is a health insights exchange platform that leverages its proprietary clinical trial matching artificial intelligence (AI) technology to address the inefficiencies of cancer clinical trials. The platform serves as a bridge between leading regional healthcare institutions and contract research organizations (CROs) and global biotechnology and pharmaceutical companies to facilitate data-driven cancer clinical trials while accelerating enrolment into actively recruiting ones.
Viome is a health testing company that uses artificial intelligence (AI) to analyze an individual’s gut biology to gain insights into their health. The service offers personalized food recommendations and made-to-order supplements according to these test results.
Vaccitech is a biotechnology company developing vaccines and immunotherapies for infectious diseases, specialising in T-cell immunotherapy. Having developed the Oxford/AstraZeneca vaccine and administering over 2bn doses globally, the company was listed on NASDAQ in 2021, reaching a peak valuation of $628m.Exit
Totient is an artificial intelligence-driven drug discovery platform that identifies and harnesses human-derived antibodies from individuals with exceptional immune responses. Totient was acquired by Absci for an undisclosed amount in 2021.Exit
AMLo Biosciences is translating ground-breaking research in cancer biomarkers into a revolutionary range of prognostic and companion diagnostic products to improve patient outcomes and reduce the financial burden of cancers on global healthcare economies.